Tumor necrosis factor-α and interleukin-1β play a critical role in the resistance against lethal herpes simplex virus encephalitis

Journal of Infectious Diseases

Volumn 196, Issue 6, 2007, Pages 853-860

  Sergerie, Yan ^a   Rivest, Serge ^b   Boivin, Guy ^a,c  

^a Research Center in Infectious Diseases   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; IN SITU HYBRIDIZATION; INFLAMMATION; INNATE IMMUNITY; LIFE EXPECTANCY; MEDULLA OBLONGATA; MOUSE; NONHUMAN; NOSE INFECTION; PONS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REPLICATION;

EID: 34548490485     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520094     Document Type: Article

References (26)

1. Tyler KL. Update on herpes simplex encephalitis. Rev Neurol Dis 2004; 1:169-78.
2. Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16:17-23.
3. Rock RB, Gekker G, Hu S, et al. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004; 17:942-64.
4. Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004; 1:14.
5. Lokensgard JR, Hu S, Sheng W, et al. Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during non-productive infection with herpes simplex virus. J Neurovirol 2001; 7: 208-19.
6. Boivin G, Coulombe Z, Rivest S. Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 2002; 16:29-43.
7. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
8. McDermott MF. TNF and TNFR biology in health and disease. Cell Mol Biol 2001; 47:619-35.
9. Rossol-Voth R, Rossol S, Schutt KH, Corridori S, de Cian W, Falke D. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol 1991; 72:143-7.
10. Berkowitz C, Becker Y. Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1. Arch Virol 1992; 124:83-93.
11. Iida J, Saiki I, Ishihara C, Azuma I. Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice. Vaccine 1989; 7:229-33.
12. Biswas PS, Banerjee K, Kim B, Rouse BT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol 2004; 172:3736-44.
13. Laflamme N, Lacroix S, Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 1999; 19:10923-30.
14. Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 1995; 3:9-19.
15. Turrin NP, Rivest S. Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 2006; 26:143-51.
16. Boivin G, Goyette N, Sergerie Y, Keays S, Booth T. Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis. J Clin Virol 2006; 37:248-51.
17. Sergerie Y, Boivin G, Gosselin D, Rivest S. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis. J Infect Dis 2007; 195:817-25.
18. Laflamme N, Soucy G, Rivest S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem 2001; 79:648-57.
19. Laflamme N, Echchannaoui H, Landmann R, Rivest S. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria. Eur J Immunol 2003; 33:1127-38.
20. Blais V, Rivest S. Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J Immunol 2004; 172: 7043-52.
21. Soulet D, Rivest S. Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system. J Cell Biol 2003; 162:257-68.
22. Shimeld C, Whiteland JL, Williams NA, Easty DL, Hill TJ. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J Gen Virol 1997; 78: 3317-25.
23. Feduchi E, Alonso MA, Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J Virol 1989; 63:1354-9.
24. Chen SH, Oakes JE, Lausch RN. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res 1994; 25:201-13.
25. Lundberg P, Welander PV, Edwards CK III, van Rooijen N, Cantin E. TNF protects resistant C57BL/6 mice against herpes simplex virus induced encephalitis independently of signaling via TNFR1 or TNFR2. J Virol 2007; 81:1451-60.
26. Marques CP, Hu S, Sheng W, Lokensgard JR. Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res 2006; 121:1-10.